• Samuel P. Hammar
  • Ronald F. Dodson


Few substances have created as much interest, fear, and misunderstanding as asbestos. In 1971, asbestos became the first material to be regulated by the Occupational Safety and Health Administration. In 1982, lawsuits filed on behalf of workers suffering from asbestos-related pulmonary disease led one asbestos products producer to file for bankruptcy, primarily as a result of claims for asbestos injury from asbestos products his company produced. Even as of the 1990s, controversies still exist concerning the toxicity and potential health effects of asbestos.


Idiopathic Pulmonary Fibrosis Asbestos Exposure Parietal Pleura Asbestos Fiber Chrysotile Asbestos 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Webster’s medical dictionary. Springfield: Merriam-Webster, 1986:51.Google Scholar
  2. 2.
    Weill H, Abraham JL, Balmes JR, et al. Health effects of tremolite. Am Rev Respir Dis 1990; 142: 1453–1458.CrossRefGoogle Scholar
  3. 3.
    Occupational exposure to asbestos, tremolite, anthophyllite and actinolite: Final rule. Department of Labor. Fed Reg 1992; 57 (110): 24310–24331.Google Scholar
  4. 4.
    Henderson DW, Shilkin KB, Whitaker D. Introduction and historical aspects, with comments on mesothelioma registries. In: Henderson DW, Shilkin KB, Langlois SL, Whitaker D, eds. Malignant mesothelioma. New York: Hemisphere, 1992: 1–22.Google Scholar
  5. 5.
    Pooley FD. Asbestos mineralogy. In: Antman K, Aisner J, eds. Asbestos-related malignancy. Orlando: Grune * Stratton, 1987: 3–27.Google Scholar
  6. 6.
    Teta MJ, Lewinsohn HC, Meigs JW, Vidone RA, Mowad LZ, Flannery JT. Mesothelioma in Connecticut, 1955–1977. J Occup Med 1983; 25: 749–756.PubMedCrossRefGoogle Scholar
  7. 7.
    Marchand F. Uber eigentumliche pigmentkristalle in den lungen. Verh Dtsch Ges Pathol 1906; 17: 223–228.Google Scholar
  8. 8.
    Cooke WE. Asbestos dust and the curious bodies found in pulmonary asbestosis. Br Med J 1929; 2: 578–580.PubMedCrossRefGoogle Scholar
  9. 9.
    Gloyne SR. The formation of the asbestos body in the lung. Tubercle 1931; 12: 399–401.CrossRefGoogle Scholar
  10. 10.
    Craighead JE, Abraham JL, Churg A, et al. Asbestos-associated diseases. Arch Pathol Lab Med 1982; 106: 542–596.Google Scholar
  11. 11.
    Barclay WR, Craighead JE, Cugell DW, et al. A physician’s guide to asbestos-related diseases. JAMA 1984; 252: 2593–2597.CrossRefGoogle Scholar
  12. 12.
    Gross P, deTreville RTP, Cralley LJ, Davis JMG. Pulmonary ferruginous bodies. Arch Pathol 1968; 85: 539–546.PubMedGoogle Scholar
  13. 13.
    Gross P, Tuma J, deTreville RTP. Unusual ferruginous bodies. Arch Environ Health 1971; 22: 534–537.Google Scholar
  14. 14.
    Timbrell V. The inhalation of fibrous dusts. Ann NY Acad Sci 1965; 132: 255–273.PubMedCrossRefGoogle Scholar
  15. 15.
    Dodson RF, Williams MG, Hurst GA. Acute lung response to amosite asbestos: A morphological study. Environ Res 1983; 32: 80–90.PubMedCrossRefGoogle Scholar
  16. 16.
    Davis JMG. Further observations on the ultrastructure and chemistry of the formation of asbestos bodies. Exp Mol Pathol 1970; 13: 346–358.PubMedCrossRefGoogle Scholar
  17. 17.
    Suzuki Y. Interaction of asbestos with alveolar cells. Environ Health Perspect 1974; 9: 241–252.PubMedCrossRefGoogle Scholar
  18. 18.
    Brody AR, Hill LH, Adkins B, O’Connor RW. Chrysotile asbestos inhalation in rats: Deposition pat-tern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis 1981; 123: 670–679.PubMedGoogle Scholar
  19. 19.
    Davis JMG. Electron microscope studies of asbestosis in man and animals. Ann NY Acad Sci 1965; 132: 98–111.PubMedCrossRefGoogle Scholar
  20. 20.
    Suzuki Y, Churg J. Structure and development of the asbestos body. Am J Pathol 1969; 55: 79–107.PubMedGoogle Scholar
  21. 21.
    Pooley FD. Asbestos bodies, their formation, composition and character. Environ Res 1972; 5: 363–379.PubMedCrossRefGoogle Scholar
  22. 22.
    Botham SK, Holt PF. The mechanism of formation of asbestos bodies. J Pathol Bacteriol 1968; 96: 443–453.PubMedCrossRefGoogle Scholar
  23. 23.
    Davis JMG. The ultrastructure of asbestos bodies from human lung. Br J Exp Pathol 1964; 45: 642.PubMedGoogle Scholar
  24. 24.
    Holt PF, Mills J, Young DK. Experimental asbestosis in the guinea pig. J Pathol Bacteriol 1966; 92: 185–195.PubMedCrossRefGoogle Scholar
  25. 25.
    Davis JMG. The ultra structure of asbestos from guinea pig lungs. Br J Exp Pathol 1964; 45: 634.PubMedGoogle Scholar
  26. 26.
    Godwin MC, Jagatic JJ. Asbestos and mesotheliomas. Environ Res 1970; 3: 391–416.CrossRefGoogle Scholar
  27. 27.
    Holmes A, Morgan A, Davison W. Formation of pseudo-asbestos bodies on sized glass fibres in the hamster lung. Ann Occup Hyg 1983; 27: 301–313.PubMedCrossRefGoogle Scholar
  28. 28.
    Churg A, Warnock ML. Analysis of the cores of ferruginous (asbestos) bodies from the general population. III. Patients with environmental exposure. Lab Invest 1979; 40: 622–626.PubMedGoogle Scholar
  29. 29.
    Churg A, Warnock ML. Analysis of the cores of ferruginous (asbestos) bodies from the general population.I. Patients with and without lung cancer. Lab Invest 1977; 37: 280–286.PubMedGoogle Scholar
  30. 30.
    Churg A, Warnock ML. Asbestos and other ferruginous bodies. Am J Pathol 1981; 102: 447–456.PubMedGoogle Scholar
  31. 31.
    Langer AM, Rubin IB, Selikoff IJ. Chemical characterization of asbestos body cores by electron microprobe analysis. J Histochem Cytochem 1972; 20: 723–734.PubMedCrossRefGoogle Scholar
  32. 32.
    Gross P, deTreville RTP. Pulmonary ferruginous bodies in city dwellers. Arch Environ Health 1969; 19: 186–188.PubMedGoogle Scholar
  33. 33.
    Churg A, Warnock ML. Analysis of the cores of asbestos bodies from members of the general population: Patients with probable low-degree exposure to asbestos. Am Rev Respir Dis 1979; 120: 781–786.PubMedGoogle Scholar
  34. 34.
    Dodson RF, O’Sullivan MF, Williams MG, Hurst GA. Analysis of cores of ferruginous bodies from former asbestos workers. Environ Res 1982; 28: 171–178.PubMedCrossRefGoogle Scholar
  35. 35.
    Warnock ML, Isenberg W. Asbestos burden and the pathology of lung cancer. Chest 1986; 89: 20–26.PubMedCrossRefGoogle Scholar
  36. 36.
    Holden J, Churg A. Asbestos bodies and the diagnosis of asbestosis in chrysotile workers. Environ Res 1986; 39: 232–236.PubMedCrossRefGoogle Scholar
  37. 37.
    Roggli VL, Pratt PC. Numbers of asbestos bodies on iron-stained tissue sections in relation to asbestos body counts in lung tissue digests. Hum Pathol 1983; 14: 355–361.PubMedCrossRefGoogle Scholar
  38. 38.
    Warnock ML, Wolery G. Asbestos bodies or fibers and the diagnosis of asbestosis. Environ Res 1987; 44: 2944.Google Scholar
  39. 39.
    Dodson RF, Williams MG, O’Sullivan MF, Corn CJ, Greenberg SD, Hurst GA. A comparison of the ferrug-inous body and uncoated fiber content in the lungs of former asbestos workers. Am Rev Respir Dis 1985; 132: 143–147.PubMedGoogle Scholar
  40. 40.
    Churg A, Warnock ML, Green N. Analysis of the cores of ferruginous (asbestos) bodies from the general population. Lab Invest 1979; 40: 31–38.PubMedGoogle Scholar
  41. 41.
    Mueller PK, Stanley RL. Asbestos fiber atlas. Washington, DC: U.S. Environmental Protection Agency, 1975: 9–19.Google Scholar
  42. 42.
    Hendry NW. The geology occurrences and major uses of asbestos. In: Boland B, ed. Annals of the New York Academy of Sciences. 132d ed. New York: New York Academy of Sciences, 1965: 12.Google Scholar
  43. 43.
    Clifton RA. Asbestos. In: Bureau of Mines, ed. Bureau of Mines mineral yearbook. Washington, DC: U.S. Department of the Interior, 1973: 1–5.Google Scholar
  44. 44.
    Wagner JC. The significance of asbestos in tissue. Recent Results Cancer Res 1972; 39: 37–46.PubMedCrossRefGoogle Scholar
  45. 45.
    Dodson RF, Williams MG, Hurst GA. Method for removing the ferruginous coating from asbestos bodies. J Toxicol Environ Health 1983; 11: 959–966.PubMedCrossRefGoogle Scholar
  46. 46.
    Telischi M, Rubenstone AI. Pulmonary asbestosis. Arch Pathol 1961; 72: 116–125.Google Scholar
  47. 47.
    Langer AM. Inorganic particles in human tissues and their association with neoplastic disease. Environ Health Perspect 1974; 9: 229–233.PubMedCrossRefGoogle Scholar
  48. 48.
    Auerbach O, Conston AS, Garfinkel L, Parks VR, Kaslow HD, Hammond EC. Presence of asbestos bodies in organs other than the lung. Chest 1980; 77: 133–137.PubMedCrossRefGoogle Scholar
  49. 49.
    Keal EE. Asbestosis and abdominal neoplasms. Lancet 1960;ii:1211–1216.Google Scholar
  50. 50.
    Dodson RF, Williams MG, Corn CJ, Brollo A, Bianchi C. Asbestos content of lung tissue, lymph nodes and pleural plaques from former shipyard workers. Am Rev Respir Dis 1990; 142: 843–847.PubMedCrossRefGoogle Scholar
  51. 51.
    Roggli VL, Benning TL. Asbestos bodies in pulmonary hilar lymph nodes. Mod Pathol 1990; 3: 513–517.PubMedGoogle Scholar
  52. 52.
    Szendroi M, Nemeth L, Vajta G. Asbestos bodies in a bile duct cancer after occupational exposure. Environ Res 1983; 30: 270–280.PubMedCrossRefGoogle Scholar
  53. 53.
    Rosen P, Gordon P, Savino A, Melamed M. Ferruginous bodies in benign fibrous plural plaques. Am J Clin Pathol 1973; 60: 608–617.PubMedGoogle Scholar
  54. 54.
    Kobayashi H, Ming ZW, Watanabe H, Ohnishi Y. A quantitative study on the distribution of asbestos bodies in extrapulmonary organs. Acta Pathol Jpn 1987; 37: 375–383.PubMedGoogle Scholar
  55. 55.
    Kanazawa K, Birbeck MSC, Carter RL, Roe FJC. Migration of asbestos fibres from subcutaneous injection sites in mice. Br J Cancer 1970; 24: 96, 106.Google Scholar
  56. 56.
    Koerten HK, de Bruijn JD, Daems WT. The formation of asbestos bodies by mouse peritoneal macrophages. Am J Pathol 1990; 137: 121–134.PubMedGoogle Scholar
  57. 57.
    Cook PM, Glass GE, Tucker JH. Asbestiform amphibole minerals: Detection and measurement of high concentrations in municipal water supplies. Science 1974; 185: 853–855.PubMedCrossRefGoogle Scholar
  58. 58.
    Millette JR, Clark PJ, Stober J, Rosenthal M. Asbestos in water supplies of the United States. Environ Health Perspect 1983; 53: 45–48.PubMedCrossRefGoogle Scholar
  59. 59.
    Cotruvo JA. Asbestos in drinking water: A status report. Environ Health Perspect 1983; 53: 181–183.PubMedGoogle Scholar
  60. 60.
    Toft P, Meek ME. Asbestos in drinking water: A Canadian view. Environ Health Perspect 1983; 53: 177–180.PubMedCrossRefGoogle Scholar
  61. 61.
    Biles B, Emerson TR. Examination of fibers in beer. Nature (London) 1968; 219: 93–94.CrossRefGoogle Scholar
  62. 62.
    Gaudichet A, Bientz M, Sebastien P, et al. Asbestos fibers in wines: relation to filtration process. J Toxicol Environ Health 1978; 4: 853–860.PubMedCrossRefGoogle Scholar
  63. 63.
    Selikoff IJ, Lee DHK. Historical background. In: Lee DHK, Hewson EW, Okun D, eds. Asbestos and disease. New York: Academic Press, 1978: 3–8.CrossRefGoogle Scholar
  64. 64.
    Churg A. The diagnosis of asbestosis. Hum Pathol 1989; 20: 97–99.PubMedCrossRefGoogle Scholar
  65. 65.
    Williams E. “Curious bodies” found in the lungs of coal-workers. Lancet 1934;ii:541–542.Google Scholar
  66. 66.
    Masse S, Begin R, Cantin A. Pathology of silicon carbide pneumoconiosis. Mod Pathol 1988; 1: 104–108.PubMedGoogle Scholar
  67. 67.
    Dodson RF, O’Sullivan MF, Corn C, Williams MG, Hurst GA. Ferruginous body formation on a nonasbestos mineral. Arch Pathol Lab Med 1985; 109: 849–852.PubMedGoogle Scholar
  68. 68.
    Churg A, Wiggs B. Mineral particles, mineral fibers, and lung cancer. Environ Res 1985; 37: 364–372.PubMedCrossRefGoogle Scholar
  69. 69.
    Churg A. Asbestos fiber content of the lungs in patients with and without asbestos airways disease. Am Rev Respir Dis 1983; 127: 470–473.PubMedGoogle Scholar
  70. 70.
    Dodson RF, Williams MG, Corn CJ, Brollo A, Bianchi C. Non-asbestos fibre burden in individuals exposed to asbestos. In: Brown RC, Hoskins JA, Johnson NF, eds. Mechanisms in fibre carcinogenesis. New York: Plenum, 1991: 29–37.CrossRefGoogle Scholar
  71. 71.
    Omenn GS, Merchant J, Boatman E, et al. Contribution of environmental fibers to respiratory cancer. Environ Health Perspect 1986; 70: 51–56.PubMedCrossRefGoogle Scholar
  72. 72.
    Langer AM. Chrysotile asbestos in the lungs of persons in New York City. Arch Environ Health 1971; 22: 348–361.PubMedGoogle Scholar
  73. 73.
    Langer AM, Pooley FD. Identification of single asbestos fibres in human tissues. In: Biological effects of asbestos. Lyon: International Agency for Research on Cancer, 1973: 119–125.Google Scholar
  74. 74.
    Dodson RF, Williams MG, Corn CJ, Brollo A, Bianchi C. A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques. Ann NY Acad Sci 1991; 643: 53–60.PubMedCrossRefGoogle Scholar
  75. 75.
    Champness PE, Cliff G, Lorimer GW. The identification of asbestos. J Microsc 1976; 108: 231–249.CrossRefGoogle Scholar
  76. 76.
    Millette JR, Twyman JD, Hansen EC, Clark PJ, Pansing MF. Chrysotile, palygorskite, and halloysite in drinking water. Scand Electron Microsc 1979; 1: 579–586.Google Scholar
  77. 77.
    Berkley C, Churg J, Selikoff IJ, Smith WE: The detection and localization of mineral fibers in tissue. In: Boland B, Hitchcock J, Kates S, eds. Biological effects of asbestos. 132d, New York: New York Academy of Sciences, 1965: 48–63.Google Scholar
  78. 78.
    Carter RE, Taylor WF. Identification of a particular amphibole asbestos fiber in tissue of persons exposed to a high oral intake of the mineral. Environ Res 1980; 24: 85–93.CrossRefGoogle Scholar
  79. 79.
    Pooley FD. Electron microscope characteristics of inhaled chrysotile asbestos fibers. Br J Ind Med 1972; 29: 146–153.PubMedGoogle Scholar
  80. 80.
    Chatfield EJ. Preparation and analysis of particulate samples by electron microscopy, with special reference to asbestos. Scanning Electron Microsc 1979; 1: 563–578.Google Scholar
  81. 81.
    Chatfield EJ, Dillon MJ. Some aspects of specimen preparation and limitations of precision in particulate analysis by SEM and TEM. Scanning Electron Microsc 1978; 1: 487–496.Google Scholar
  82. 82.
    Ashcroft T, Heppleston AG. The optical and electron microscopic determination of pulmonary asbestos fiber concentration and its relation to the human pathological reaction. J Clin Pathol 1973; 26: 224–234.PubMedCrossRefGoogle Scholar
  83. 83.
    Churg A, Warnock ML. Asbestos fiber in the general population. Am Rev Respir Dis 1980; 122: 669–678.PubMedGoogle Scholar
  84. 84.
    Stasny JT, Husach C, Albright FR, Schumacher DV, Sweigart DW, Boyer K. Development of methods to isolate asbestos from spiked beverages and foods for SEM characterization. Scanning Electron Microsc 1979; 1: 587–595.Google Scholar
  85. 85.
    Sundius N, Bygden A. Isolation of the mineral dust in lungs and sputum. J Ind Hyg Toxicol 1938; 20: 351–359.Google Scholar
  86. 86.
    Vallyathan V, Green FHY. The role of analytical techniques in the diagnosis of asbestos-associated disease. CRC Crit Rev Clin Lab Sci 1985; 22: 1–42.Google Scholar
  87. 87.
    Gylseth B, Baunan RH, Bruun R. Analysis of inorganic fibre concentrations in biological samples by scanning electron microscopy. Scand J Work Environ Health 1981; 7: 101–108.PubMedCrossRefGoogle Scholar
  88. 88.
    Gylseth B, Baunan RH. Topographic and size distribution of asbestos bodies in exposed human lungs. Scand J Work Environ Health 1981; 7: 190–195.PubMedCrossRefGoogle Scholar
  89. 89.
    O’Sullivan MF, Corn CJ, Dodson RE. Comparative efficiency of Nuclepore filters of various pore sizes as used in digestion studies of tissue. Environ Res 1987; 43: 97–103.PubMedCrossRefGoogle Scholar
  90. 90.
    Gloyne SR. The presence of the asbestos fibre in the lesions of asbestos workers. Tubercle 1929; 10: 404–407.CrossRefGoogle Scholar
  91. 91.
    Sebastien P, Masse R, Bignon J. Recovery of ingested asbestos fibers from the gastrointestinal lymph in rats. Environ Res 1980; 22: 201–216.PubMedCrossRefGoogle Scholar
  92. 92.
    Williams MG, Dodson RF, Corn C, Hurst GA. A procedure for the isolation of amosite asbestos and ferruginous bodies from lung tissue and sputum. J Toxicol Environ Health 1982; 10: 627–638.PubMedCrossRefGoogle Scholar
  93. 93.
    Gross P, Detreville RT. The lung as an embattled domain against inanimate pollutants. Am Rev Respir Dis 1972;106:684–691.Google Scholar
  94. 94.
    Evans JC, Evans RJ, Holmes A, et al. Studies on the deposition of inhaled fibrous material in the respiratory tract of the rat and its subsequent clearance using radioactive tracer techniques. Environ Res 1973; 6: 180–201.PubMedCrossRefGoogle Scholar
  95. 95.
    Pinkerton KE, Pratt PC, Brody AR, Crapo JD. Fiber localization and its relationship to lung reaction in rats after chronic inhalation of chrysotile asbestos. Am J Pathol 1984; 117: 484–498.PubMedGoogle Scholar
  96. 96.
    Coin PG, Roggli VL, Brody AR. Deposition, clearance, and translocation of chrysotile asbestos from peripheral and central regions of the rat lung. Environ Res 1992; 58: 97–116.PubMedCrossRefGoogle Scholar
  97. 97.
    Lauweryns JM, Baert JH. Alveolar clearance and the role of the pulmonary lymphatics. Am Rev Respir Dis 1977; 115: 625–683.PubMedGoogle Scholar
  98. 98.
    Spencer H. The anatomy of the lung. In: Pathology of the lung. 4th Ed. Oxford: Pergamon, 1985: 417.Google Scholar
  99. 99.
    McMillan CH, Jones AD, Vincent JH, Johnston AM, Douglas AN, Cowie H. Accumulation of mixed mineral dusts in the lungs of rats during chronic inhalation exposure. Environ Res 1989; 48: 218–237.PubMedCrossRefGoogle Scholar
  100. 100.
    Fishman AP. Pulmonary diseases and disorders. New York: McGraw-Hill, 1980: 638.Google Scholar
  101. 101.
    Viallat JR, Raybuad F, Passarel M, Boutin C. Pleural migration of chrysotile fibers after intratracheal injection in rats. Arch Environ Health 1986; 41: 282–286.PubMedCrossRefGoogle Scholar
  102. 102.
    Hallenbeck WH, Patel-Mandlik KJ. Presence of fibers in the urine of a baboon gavaged with chrysotile asbestos. Environ Res 1979; 20: 335–340.PubMedCrossRefGoogle Scholar
  103. 103.
    Cook PM, Olson GF. Ingested mineral fibers: Elimina- tion in human urine. Science 1979; 204: 195–198.PubMedCrossRefGoogle Scholar
  104. 104.
    Hague AK, Mancuso MG, Williams MG, Dodson RF. Asbestos in organs and placenta of five stillborn infants suggests transplacental transfer. Environ Res 1992; 58: 163–175.CrossRefGoogle Scholar
  105. 105.
    Dement JM. Overview: Workshop of fiber toxicology research needs. Environ Health Perspect 1990; 88: 261–268.PubMedGoogle Scholar
  106. 106.
    U.S. Environmental Protection Agency. Asbestos-containing materials in schools. Fed Reg 1991;40 CFR 763, Subpt. E, App. A, p. 494.Google Scholar
  107. 107.
    Morgan A, Holmes A. The distribution and characteristics of asbestos fibers in the lungs of Finnish anthophyllite mine-workers. Environ Res 1984; 33: 62–75.PubMedCrossRefGoogle Scholar
  108. 107a.
    Case BW, Sebastien P, McDonald JC. Lung fiber analysis in accident victims: A biological assessment of general environmental exposures. Arch Environ Health 1988; 43: 178–179.PubMedCrossRefGoogle Scholar
  109. 107b.
    Warnock ML, Wolery G. Asbestos bodies or fibers and the diagnosis of asbestosis. Environ Res 1987; 44: 29–44.PubMedCrossRefGoogle Scholar
  110. 108.
    Dodson RF, O’Sullivan MF, Corn CJ. Technique dependent variations in asbestos burden as illustrated in a case of nonoccupational exposed mesothelioma. Am J Ind Med 1993; 24: 235–240.PubMedCrossRefGoogle Scholar
  111. 109.
    Roggli VL, Pratt PC, Brody AR. Asbestos content of lung tissue in asbestos-associated diseases. A study of 110 cases. Br J Ind Med 1986; 43: 18–28.PubMedGoogle Scholar
  112. 110.
    Churg A. Fiber counting and analysis in the diagnosis of asbestos-related disease. Hum Pathol 1982; 13: 381–392.PubMedCrossRefGoogle Scholar
  113. 111.
    Churg A, Wiggs B, Depaoli L, Kampe B, Stevens B. Lung asbestos content in chrysotile workers with mesothelioma. Am Rev Respir Dis 1984; 130: 1042–1045.PubMedGoogle Scholar
  114. 112.
    McDonald AD, McDonald JC, Pooley FD. Mineral fibre content of lung in mesothelial tumours in North America. Ann Occup Hyg 1982; 26: 417–422.PubMedCrossRefGoogle Scholar
  115. 113.
    Breedin PH, Buss DH. Ferruginous (asbestos) bodies in the lungs of rural dwellers, urban dwellers and patients with pulmonary neoplasms. South Med J 1976; 69: 401–404.PubMedCrossRefGoogle Scholar
  116. 114.
    Dodson RF, Greenberg SD, Williams MG, Corn CJ, O’Sullivan MF, Hurst GA. Asbestos content in lungs of occupationally and nonoccupationally exposed individuals. JAMA 1984; 252: 68–71.PubMedCrossRefGoogle Scholar
  117. 115.
    Becklane MR. Asbestos-related diseases of the lung and other organs: Their epidemiology and implications for clinical practice. Am Rev Respir Dis 1976; 114: 187–227.Google Scholar
  118. 116.
    Hillerdal G. The pathogenesis of pleural plaques and pulmonary asbestosis: Possibilities and impossibilities. Eur J Respir Dis 1980; 61: 129–138.PubMedGoogle Scholar
  119. 117.
    Churg A, Green FHY. Pathology of occupational lung disease. New York: Igaku-Shoin, 1988: 213–277.Google Scholar
  120. 118.
    Churg A. Nonasbestos pulmonary mineral fibers in the general population. Environ Res 1983; 31: 189–200.PubMedCrossRefGoogle Scholar
  121. 119.
    Fulmer JD. Bronchoalveolar lavage. Am Rev Respir Dis 1982; 126: 961–962.PubMedGoogle Scholar
  122. 120.
    Crystal RG, Reynolds HY, Kalica AR. Bronchoalveolar lavage. The report of an international conference. Chest 1986; 90: 122–131.PubMedCrossRefGoogle Scholar
  123. 121.
    Springmeyer SC. The clinical use of bronchoalveolar lavage. Chest 1987; 92: 771–772.PubMedCrossRefGoogle Scholar
  124. 122.
    Craighead JE, Mossman BT. The pathogenesis of asbestos-associated diseases. N Engl J Med 1982; 306: 1446–1455.PubMedCrossRefGoogle Scholar
  125. 123.
    De Vuyst P, Dumortier P, Leophonte P, Vande Weyer R, Yernault JC. Mineralogical analysis of bronchoalveolar lavage in talc pneumoconiosis. Eur J Respir Dis 1987; 70: 150–156.PubMedGoogle Scholar
  126. 124.
    De Vuyst P, Dumortier P, Moulin E, et al., Asbestos bodies in bronchoalveolar lavage reflect lung asbestos body concentration. Eur Respir J 1988; 1: 362–367.PubMedGoogle Scholar
  127. 125.
    De Vuyst P, Dumortier P, Moulin E, Yourassowsky N, Yernault JC. Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid. Am Rev Respir Dis 1987; 136: 1219–1224.PubMedCrossRefGoogle Scholar
  128. 126.
    De Vuyst P, Jedwab J, Dumortier P, Vandermoten G, Vande Weyer R, Yernault JC. Asbestos bodies in bronchoalveolar lavage. Am Rev Respir Dis 1982; 126: 972–976.PubMedGoogle Scholar
  129. 127.
    De Vuyst P, Mairesse M, Gaudichet A, Dumortier P, Jedwab J, Yernault JC. Mineralogical analysis of bronchoalveolar lavage fluid as an aid to diagnosis of “imported” pleural asbestosis. Thorax 1983; 38: 628–629.PubMedCrossRefGoogle Scholar
  130. 128.
    Dodson RF, Garcia JGN, O’Sullivan M, et al. The usefulness of bronchoalveolar lavage in identifying past occupational exposure to asbestos: A light and electron microscopy study. Am J Ind Med 1991; 19: 619–628.PubMedCrossRefGoogle Scholar
  131. 129.
    Stewart MJ, Haddow AC. Demonstration of the peculiar bodies of pulmonary asbestos in material obtained by lung puncture and in the sputum. J Pathol Bacteriol 1929; 32: 1782.CrossRefGoogle Scholar
  132. 130.
    McLarty JW, Greenberg SD, Hurst GA, et al. The clinical significance of ferruginous bodies in sputa. J Occup Med 1980; 22: 92–96.PubMedCrossRefGoogle Scholar
  133. 131.
    Roggli VL, Greenberg SD, McLarty JW, et al. Comparison of sputa and lung asbestos body counts in former asbestos workers. Am Rev Respir Dis 1980; 122: 941.PubMedGoogle Scholar
  134. 132.
    Modin BE, Greenberg SD, Buffler PA, Lockhart JA, Seitzman LH, Awe RJ. Asbestos bodies in a general hospital/clinic population. Acta Cytol 1982; 26: 667–670.PubMedGoogle Scholar
  135. 133.
    Dodson RF, Williams MG, Corn CJ, Idell S, McLarty JW. Usefulness of combined light and electron microscopy evaluation of sputum samples for asbestos to determine past occupational exposure. Mod Pathol 1989; 2: 320–322.PubMedGoogle Scholar
  136. 134.
    Farley ML, Greenberg SD, Shuford EH, Hurst GA, Spivey CG, Christianson C. Ferruginous bodies in sputa of former asbestos workers. Acta Cytol 1977; 21: 693.PubMedGoogle Scholar
  137. 135.
    Churg A, Wood P. Observations on the distribution of asbestos fibers in human lungs. Environ Res 1983; 31: 374–380.PubMedCrossRefGoogle Scholar
  138. 136.
    Churg A, Wiggs B. The distribution of amosite asbestos fibers in the lungs of workers with mesothelioma or carcinoma. Exp Lung Res 1989; 15: 771–783.PubMedCrossRefGoogle Scholar
  139. 137.
    Dodson RF, Hurst GA, Williams MG, Corn CJ, Greenberg SD. Comparison of light and electron microscopy for defining occupational asbestos exposure in trans-bronchial lung biopsies. Chest 1988; 94: 366–370.PubMedCrossRefGoogle Scholar
  140. 138.
    Pritchard JN. Dust overloading causes impairment of pulmonary clearance: Evidence from rats and humans. Exp Pathol 1989;37:39–42.Google Scholar
  141. 139.
    Cohen D, Arai SF, Brain JD. Smoking impairs longterm dust clearance from the lung. Science 1979; 204: 514–517.PubMedCrossRefGoogle Scholar
  142. 140.
    McFadden D, Wright JL, Wiggins B, Churg A. Smoking inhibits asbestos clearance. Am Rev Respir Dis 1986; 133: 372–374.PubMedGoogle Scholar
  143. 141.
    McFadden D, Wright J, Wiggs B, Churg A. Cigarette smoke increases the penetration of asbestos fibers into airway walls. Am J Pathol 1986; 123: 95–99.PubMedGoogle Scholar
  144. 142.
    Stanton MF, Wrench C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst 1972; 48: 797–821.PubMedGoogle Scholar
  145. 143.
    Stanton MF, Layard M, Tegeris A, Miller E, May M, Kent E. Carcinogenicity of fibrous glass: Pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst 1977; 58: 587–603.PubMedGoogle Scholar
  146. 144.
    Stanton MF, Layard M, Tegeris E, et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst 1981; 67: 965.PubMedGoogle Scholar
  147. 145.
    Selikoff IJ. Historical developments and perspectives in inorganic fiber toxicity in man. Environ Health Perspect 1990; 88: 269–276.PubMedCrossRefGoogle Scholar
  148. 146.
    Wagner JC. Asbestos cancers. J Natl Cancer Inst 1979; 52: 41–46.Google Scholar
  149. 147.
    Wagner JC, Pooley FD, Berry G, et al. A pathological and mineralogical study of asbestos-related deaths in the United Kingdom in 1977. Ann Occup Hyg 1982; 26: 423–431.PubMedCrossRefGoogle Scholar
  150. 148.
    Churg A. Chrysotile, tremolite, and malignant mesothelioma in man. Chest 1988; 93: 621–628.PubMedCrossRefGoogle Scholar
  151. 149.
    Wagner JC. Mesothelioma and mineral fibers. Cancer (Philadelphia) 1986; 57: 1905–1911.CrossRefGoogle Scholar
  152. 150.
    Merchant JA. Human epidemiology: A review of type and characteristics in the development of malignant and nonmalignant disease. Environ Health Perspect 1990; 88: 287–293.PubMedCrossRefGoogle Scholar
  153. 151.
    Begin R, Gauthier JJ, Desmeules M, Ostiguy G. Work-related mesothelioma in Quebec, 1967–1990. Am J Ind Med 1992; 22: 531–542.PubMedCrossRefGoogle Scholar
  154. 152.
    Sebastien P, McDonald JC, McDonald AD, Case B, Harley R. Respiratory cancer in chrysotile textile and mining industries: Exposure inferences from lung analysis. Br J Ind Med 1989; 46: 180–187.PubMedGoogle Scholar
  155. 153.
    Dement JM. Carcinogenicity of chrysotile asbestos: A case control study of textile workers. Cell Biol Toxicol 1991; 7: 59–65.PubMedCrossRefGoogle Scholar
  156. 154.
    Davis JMG, Jones AD. Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol 1988; 69: 717–737.PubMedGoogle Scholar
  157. 155.
    Pott F. Problems in defining carcinogenic fibres. Ann Occup Hyg 1987; 31: 799–802.PubMedCrossRefGoogle Scholar
  158. 156.
    Pott F, Roller M, Ziem U, et al. Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. In: Symposium on mineral fibres in the non-occupational environment, Lyon, September 8–10, 1987. 1988: 1–4.Google Scholar
  159. 157.
    Pott F, Ziem U, Reiffer FJ, Huth F, Ernst H, Mohr U. Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats. Exp Pathol 1987; 32: 129–152.PubMedCrossRefGoogle Scholar
  160. 158.
    Lippmann M. Asbestos exposure indices. Environ Res 1988; 46: 86–106.PubMedCrossRefGoogle Scholar
  161. 159.
    Churg A, Wright JL, Gilks B, Depaoli L. Rapid short-term clearance of chrysotile compared with amosite asbestos in the guinea pig. Am Rev Respir Dis 1989; 139: 885–890.PubMedCrossRefGoogle Scholar
  162. 160.
    Churg A, Wright J, Wiggs B, Depaoli L. Mineralogic parameters related to amosite asbestos-induced fibrosis in humans. Am Rev Respir Dis 1990; 142: 1331–1336.PubMedCrossRefGoogle Scholar
  163. 161.
    U.S. Environmental Protection Agency. Asbestos-containing materials in schools: Final rule and notice. 40 CFR Part 763, Fed. Reg. 1987;52:41826 41905.Google Scholar
  164. 162.
    Warheit DB, Overby LH, George G, Brody AR. Pulmonary macrophages are attracted to inhaled particles through complement activation. Exp Lung Res 1988; 14: 51–66.PubMedCrossRefGoogle Scholar
  165. 163.
    Till GO, Ward PA. Systemic complement activation and acute lung injury. Fed Proc 1986; 45: 13–18.PubMedGoogle Scholar
  166. 164.
    Bowden DH. Macrophages, dust, and pulmonary diseases. Exp Lung Res 1987; 12: 89–107.CrossRefGoogle Scholar
  167. 165.
    du Bois RM. Advances in our understanding of the pathogenesis of fibrotic lung disease. Respir Med 1990; 84: 185–187.PubMedCrossRefGoogle Scholar
  168. 166.
    Shaw RJ, Benedict SH, Clark RAF, King TE. Pathogenesis of pulmonary fibrosis in interstitial lung disease. Am Rev Respir Dis 1991; 143: 167–173.PubMedCrossRefGoogle Scholar
  169. 167.
    Case BW, Micheal PC, Padilla M, Kleinerman J. Asbestos effects on superoxide production. Environ Res 1986; 39: 299–306.PubMedCrossRefGoogle Scholar
  170. 168.
    Hansen K, Mossman BT. Generation of superoxide from alveolar macrophages exposed to asbestiform and non-fibrous particles. Cancer Res 1987; 47: 1681–1686.PubMedGoogle Scholar
  171. 169.
    Hansen K, Mossman BT. Generation of superoxide from alveolar macrophages exposed to asbestiform and from alveolar macrophages exposed to asbestiform and non-fibrous particles. Cancer Res 1987; 47: 1681–1686.PubMedGoogle Scholar
  172. 170.
    Ward PA, Duque RE, Sulavik MC, Johnson KJ. In vitro and in vivo stimulation of rat neutrophils and alveolar macrophages by immune complexes. Am J Pathol 1983; 110: 297–309.PubMedGoogle Scholar
  173. 171.
    Rahman Q, Das B, Viswanathan PN. Biochemical mechanisms in asbestos toxicity. Environ Health Perspect 1983; 51: 299–303.PubMedCrossRefGoogle Scholar
  174. 172.
    Jaurand MC, Gaudichet A, Atassi K, Sebastien P, Big-non J. Relationship between the number of asbestos fibres and the cellular and enzymatic content of bronchoalveolar fluid in asbestos exposed subjects. Bull Eur Physiopathol Respir 1980; 16: 595–606.PubMedGoogle Scholar
  175. 173.
    Brain JD. Macrophage damage in relation to the pathogenesis of lung diseases. Environ Health Perspect 1980; 35: 21–28.PubMedCrossRefGoogle Scholar
  176. 174.
    Hahon N, Vallyathan V, Booth JA, Sepulveda MJ. In vitro biologic responses to native and surface-modified asbestos. Environ Res 1986; 39: 345–355.PubMedCrossRefGoogle Scholar
  177. 175.
    Hayes AA, Rose AH, Musk AW, Robinson WS. Neutrophil chemotactic factor release and neutrophil alveolitis in asbestos-exposed individuals. Chest 1988; 94: 521–525.PubMedCrossRefGoogle Scholar
  178. 176.
    Dubois CM, Bissonnette E, Rola-Pleszczynski M. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Am Rev Respir Dis 1989; 139: 1257–1264.PubMedCrossRefGoogle Scholar
  179. 177.
    Donaldson K, Li XY, Dogra S, Miller BG, Brown GM. Asbestos-stimulated tumour necrosis factor release from alveolar macrophages depends on fibre length and opsonization. J Pathol 1992; 168: 243–248.PubMedCrossRefGoogle Scholar
  180. 178.
    Zone JJ, Rom WN. Circulating immune complexes in asbestos workers. Environ Res 1985; 37: 383–389.PubMedCrossRefGoogle Scholar
  181. 179.
    Huuskonen MS, Rasanen JA, Harkonen H, Asp S. Asbestos exposure as a cause of immunological stimulation. Scand J Resp Dis 1978; 59: 326–332.Google Scholar
  182. 180.
    Valerio F, Balducci D, Lazzarotto A. Adsorption of proteins by chrysotile and crocidolite: Role of molecular weight and charge density. Environ Res 1987; 44: 312–320.PubMedCrossRefGoogle Scholar
  183. 181.
    Hamilton JA. Asbestos fibers, plasma and inflammation. Environ Health Perspect 1983; 51: 281–285.PubMedCrossRefGoogle Scholar
  184. 182.
    Bonneau L, Malard C, Pezerat H. Studies on surface properties of asbestos II. Role of dimensional characteristics and surface properties of mineral fibers in the induction of pleural tumors. Environ Res 1986; 41: 268–275.PubMedCrossRefGoogle Scholar
  185. 183.
    Jolicoeur C, Poisson D. Surface physico-chemical studies of chrysotile asbestos and related minerals. Drug Chem Toxicol 1987; 10: 1–47.PubMedCrossRefGoogle Scholar
  186. 184.
    Bonneau L, Suquet H, Malard C, Pezerat H. Studies on surface properties of asbestos I. Active sites on surface of chrysotile and amphiboles. Environ Res 1986; 41: 251–267.PubMedCrossRefGoogle Scholar
  187. 185.
    Eberhardt MK, Roman-Franco AA, Quiles MR. Asbestos-inducedfdecomposition of hydrogen peroxide. Environ Res 1985; 37: 287–292.PubMedCrossRefGoogle Scholar
  188. 186.
    Kennedy TP, Ky H, Rao NV, et al. Asbestos and kaolin cause red cell hemolysis by acting as fenton reagents. Am Rev Respir Dis 1987; 135: A166.Google Scholar
  189. 187.
    Jaurand MC. Mechanisms of fibre genotoxicity. In: Brown RC, Hoskins JA, Johnson NF, eds. Mechanisms in fibre carcinogenesis. New York: Plenum, 1991: 287–307.CrossRefGoogle Scholar
  190. 188.
    MacDonald JL, Kane AB. Identification of asbestos fibers within single cells. Lab Invest 1986; 55: 177–185.PubMedGoogle Scholar
  191. 189.
    Brody AR, Hill LH, Stirewalt WS, Adler KB. Actin-containing microfilaments of pulmonary epithelial cells provide a mechanism for translocating asbestos to the interstitium. Chest 1983; 83: 11–12.Google Scholar
  192. 190.
    Somers ANA, Mason EA, Gerwin BI, Harris CC, Lechner JF. Effects of amosite asbestos fibers on the filaments present in the cytoskeleton of primary human mesothelial cells. In: Brown RC, Hoskins JA, Johnson NF, eds. Mechanisms in fibre carcinogenesis. New York: Plenum, 1991: 481–490.CrossRefGoogle Scholar
  193. 191.
    Aust AE, Lund LG. Iron mobilization from crocidolite results in enhanced iron-catalyzed oxygen consumption and hydroxyl radical generation in the presence of cysteine. In: Brown RC, Hoskins JA, Johnson NF, eds. Mechanisms in fibre carcinogenesis. New York: Plenum, 1991: 397–405.CrossRefGoogle Scholar
  194. 192.
    Lund LG, Aust AE. Iron mobilization from crocidolite asbestos greatly enhances crocidolite-dependent formation of DNA single-strand breaks in t6X 174 RFI DNA. Carcinogenesis 1992; 13: 637–642.PubMedCrossRefGoogle Scholar
  195. 193.
    Leanderson P, Tagesson C. Hydrogen peroxide release and hydroxyl radical formation in mixtures containing mineral fibres and human neutrophils. Br J Ind Med 1992; 49: 745–749.PubMedGoogle Scholar
  196. 194.
    Lund LG, Williams MG, Dodson RF, Aust AE. Iron associated with asbestos bodies is responsible for the formation of single-strand breaks in 0X174 RFI DNA. Br J Ind Med (in press).Google Scholar
  197. 195.
    Becklane MR. Occupational lung disease: Past record and future trend using the asbestos case as a model. Clin Invest Med 1983; 6: 305–317.Google Scholar
  198. 196.
    Dressen WC, Dallavalle JM, Edward TI, Miller JM, Sayers RR. The study of asbestos in the asbestos textile industry. Public Health Bulletin No. 241. Washington, DC: U.S. Treasury Department, 1938: 1–126.Google Scholar
  199. 197.
    Merewether ERA, Price CW. Report on the effects of asbestos dust on the lungs and dust suppression in the asbestos industry. London: HM Stationery Office, 1930: 1–34.Google Scholar
  200. 198.
    Epler GR, McCloud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 1982; 247: 617–622.PubMedCrossRefGoogle Scholar
  201. 199.
    Gibbs AR, Stephens M, Griffiths DM, Blight BJN, Pooley FD. Fiber distribution in the lungs and pleura of subjects with asbestos-related diffuse pleural fibrosis. Br J Ind Med 1991; 48: 762–770.PubMedGoogle Scholar
  202. 200.
    Collins TFB. Pleural reaction associated with asbestos exposure. Br J Radiol 1968; 41: 655–661.PubMedCrossRefGoogle Scholar
  203. 201.
    Mattson S, Ringqvist T. Pleural plaques and exposure to asbestos. Scand J Respir Dis 1970; 75 (Suppl.): I - 41.Google Scholar
  204. 202.
    Mattson S. Monosymptomatic exudative pleurisy in persons exposed to asbestos dust. Scand J Respir Dis 1975; 56: 263–272.PubMedGoogle Scholar
  205. 203.
    Eisenstadt HB. Asbestos pleurisy. Dis Chest 1964; 46: 78–81.PubMedCrossRefGoogle Scholar
  206. 204.
    Hillerdal G, Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 1987; 71: 113–121.PubMedGoogle Scholar
  207. 205.
    Fondimare A, Duwoos H, Desbordes J, et al. Plaques fibroyalines calcifiees du foie dans l’asbestose. Nouv Presse Med 1973; 3: 893.Google Scholar
  208. 206.
    Andrion A, Pira E, Mollo F. Peritoneal plaques and asbestos exposure. Arch Pathol Lab Med 1983; 107: 609–610.PubMedGoogle Scholar
  209. 207.
    Wain SL, Roggli VL, Foster WL, Jr. Parietal pleural plaques, asbestos bodies, and neoplasia: A clinical, pathologic and roentgenographic correlation of 25 consecutive cases. Chest 1985; 86: 707–713.CrossRefGoogle Scholar
  210. 208.
    Schwartz DA. New developments in asbestos-induced pleural disease. Chest 1991; 99: 191–198.PubMedCrossRefGoogle Scholar
  211. 209.
    Hourihane DO, Lessof L, Richardson PC. Hyaline and calcified pleural plaques as an index of exposure to asbestos: A study of radiological and pathological features of 100 cases with a consideration of epidemiology.Br Med J 1966; 1: 1069–1074.Google Scholar
  212. 210.
    Warnock ML, Prescott BT, Kuwahara TJ. Numbers and types of asbestos fibers in subjects with pleura plaques. Am J Pathol 1982; 109: 37–46.PubMedGoogle Scholar
  213. 211.
    Rohl AN. Asbestos in talc. Environ Health Perspect 1974; 9: 129–132.PubMedCrossRefGoogle Scholar
  214. 212.
    Hillerdal G. Pleural plaques in a health survey material: Frequency, development and exposure to asbestos. Scand J Respir Dis 1978; 59: 257–263.Google Scholar
  215. 213.
    Sebastien P, Fondimare A, Bignon J, Monchaux G, Desbordes J, Bonnaud G. Topographic distribution of asbestos fibres in human lung in relation to occupational and non-occupational exposure. In: Walter WH, McGovern B, eds. Inhaled particles. New York: Perga-mon Press, 1977;4(2):435–444.Google Scholar
  216. 214.
    Whitwell F, Scott J, Grimshaw M. Relationship between occupations and asbestos fibre content of the lungs in patients with pleural mesothelioma, lung cancer, and other diseases. Thorax 1977; 32: 377–386.PubMedCrossRefGoogle Scholar
  217. 215.
    Churg A. Asbestos fibers and pleural plaques in a general autopsy population. Am J Pathol 1982; 109: 88–96.PubMedGoogle Scholar
  218. 216.
    Churg A, dePaoli L. Environmental pleural plaques in 234. residents of a Quebec chrysotile mining town. Chest 1988; 94: 58–60.PubMedCrossRefGoogle Scholar
  219. 217.
    Kishimoto T, Ono T, Okada K, Ito H. Relationship between numbers of asbestos bodies in autopsy lung and p;eural plaques on chest on chest x-ray film. Chest 1989; 95: 549–552.PubMedCrossRefGoogle Scholar
  220. 218.
    Lee KP. Lung response to particles with emphasis on asbestos and other fibrous dusts. CRC Crit Rev Toxicol 1985; 14: 33–86.CrossRefGoogle Scholar
  221. 219.
    Meurman L. Asbestos bodies and pleural plaques in a Finnish series of autopsy cases. Acta Pathol Microbiol Scand 1966; 181 (Suppl.): 7–107.Google Scholar
  222. 220.
    Roberts GH. The pathology of parietal pleural plaques. J Clin Pathol 1961; 24: 348–353.CrossRefGoogle Scholar
  223. 221.
    LeBouffant L, Martin JC, Durif S, Daniel H. Structure and composition of pleural plaques. In: Bogovski P, Gilson JC, Timbrell V, Wagner JC, eds. Biological effects of asbestos. Lyon, France: International Agency for Research on Cancer, 1973: 249–257.Google Scholar
  224. 222.
    Kiviluoto R. Pleural calcification as a roentgenologic sign of nonoccupational endemic anthophyllite asbestosis. Acta Radiol 1960; 194 (Suppl.): 1–67.Google Scholar
  225. 223.
    Wang NS. The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura. Am Rev Respir Dis 1975; 111: 12–20.PubMedGoogle Scholar
  226. 224.
    Moalli PA, MacDonald JL, Goodglick LA, Kane AB. Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am J Pathol 1987; 128: 426445.Google Scholar
  227. 225.
    Taskinen E, Ahlmon K, Wiikeri M. A current hypothesis of the lymphatic transport of inspired dust to the parietal pleura. Chest 1973; 64: 193–196.PubMedCrossRefGoogle Scholar
  228. 226.
    Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer 1974; 29: 252–269.PubMedCrossRefGoogle Scholar
  229. 227.
    Hammar SP. Controversies and uncertainties concerning the pathologic features and pathologic diagnosis of asbestosis. Semin Diagn Pathol 1992; 9: 102–109.PubMedGoogle Scholar
  230. 228.
    Stephens M, Gibbs AR, Pooley FD,Wagener TC. Asbestos-induced diffuse pleural fibrosis: Pathology and mineralogy. Thorax 1987; 583–588.Google Scholar
  231. 229.
    Gibbs AR, Stephens M, Griffiths DM, Blight BJN, Pooley FD. Fiber distribution in the lungs and pleura of subjects with asbestos-related diffuse pleural fibrosis. Br J Ind Med 1991; 48: 762–770.PubMedGoogle Scholar
  232. 230.
    Kilburn KH, Warshaw R. Pulmonary functional impairment associated with pleural asbestos disease: Circumscribed and diffuse thickening. Chest 1990; 98: 965–972.PubMedCrossRefGoogle Scholar
  233. 231.
    Loeschke H. Storungen des Lufgehalts der Lunge. In: Hanke-Lubarsch Hanbuch der Spezielleu pathologischen Anatomie und Histologie. 3. Bd, I. Teil. Berlin: Springer, 1928: 599.Google Scholar
  234. 232.
    Hanke R. Rundatelektasen (Kugel and Walzenatelektasen): Ein bietrag zur differential diagnosis intrapulmonaler rundherde. Roefo 1971; 114: 164–183.CrossRefGoogle Scholar
  235. 233.
    Blesovsky A. The folded lung. Br J Dis Chest 1966; 60: 19–22.PubMedCrossRefGoogle Scholar
  236. 234.
    Dernevik L, Gatzinsky P, Hultman E, et al. Shrinking pleuritis with atelectasis. Thorax 1982; 37: 252–258.PubMedCrossRefGoogle Scholar
  237. 235.
    Payne CR, Jaques P, Kerr IH. Lung folding simulating peripheral pulmonary neoplasm (Blesovky’s syndrome).Thorax 1980; 35: 936–940.PubMedGoogle Scholar
  238. 236.
    Sinner WN. Pleuroma. A cancer-mimicking atelectactic pseudotumor of the lung. Roefo 1980; 133: 578–585.CrossRefGoogle Scholar
  239. 237.
    Kretzschmar R. Uber atelaktatische pseudotumoren der Lunge. Roefo 1975; 122: 19–29.CrossRefGoogle Scholar
  240. 238.
    Schummelfeder N. Umfaltungen and verwachsungen an freien Lungenradem. Beitr Pathol Anal Allg Pathol 1956; 116: 422–435.Google Scholar
  241. 239.
    Giese W. Pathologische anatomie der pleuaerkrankeungen. Prax Pneumol 1972; 26: 574–587.PubMedGoogle Scholar
  242. 240.
    Mark EJ. Case 24–1983. N Engl J Med 1983; 308: 1466–1472.CrossRefGoogle Scholar
  243. 241.
    Menzies R, Fraser R. Round atelectasis: Pathologic and pathogenetic features. Am J Surg Pathol 1987; 11: 674–681.PubMedCrossRefGoogle Scholar
  244. 242.
    Chung-Park M, Tomashefski JF, Jr., Cohen AM, ElGazzar M, Cotes EE. Shrinking pleuritis with lobar atelectasis: A morphologic variant of “round atelectasis. ” Hum Pathol 1989; 20: 382–387.PubMedCrossRefGoogle Scholar
  245. 243.
    Selikoff IJ, Lee DHK. Asbestos and disease. New York: Academic Press, 1978.Google Scholar
  246. 244.
    Craighead JE. Eyes for the epidemiologist: The pathologist’s role in shaping our understanding of asbestos-associated diseases. Am J Clin Pathol 1988; 89: 281–287.PubMedGoogle Scholar
  247. 245.
    Cooke WE. Pulmonary asbestosis. Br Med J 1927; 2: 1024–1025.PubMedCrossRefGoogle Scholar
  248. 246.
    Dresen WC, Dallavalle JM, Edward TI, Miller JM, Sayers RR. A study of asbestos in the asbestos textile industry. Public Health Bulletin *24. Washington, DC: U.S. Treasury Department, 1938: 1–126.Google Scholar
  249. 247.
    Roggli VL, Shelburne JD. New concepts in the diagnosis of mineral pneumoconiosis. Semin Respir Med 1982; 4: 128–138.CrossRefGoogle Scholar
  250. 248.
    Roggli VL. Pathology of human asbestosis: A critical review. Adv Pathol 1989; 2: 31–60.Google Scholar
  251. 249.
    Roggli VL. Asbestosis. In: Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of asbestos-associated diseases. Boston: Little Brown, 1992: 77–108.Google Scholar
  252. 250.
    Warnock ML, Isenberg W. Asbestos burden and the pathology of lung cancer. Chest 1986; 89: 20–26.PubMedCrossRefGoogle Scholar
  253. 251.
    Winterbauer RH, Hammar SP, Hallman KO. Diffuse interstitial pneumonitis: Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. Am J Med 1977; 65: 661–672.CrossRefGoogle Scholar
  254. 252.
    Churg A, Sakoda N, Warnock ML. A simple method of preparing ferruginous bodies for electron microscopic examination. Am J Clin Pathol 1976; 68: 513–517.Google Scholar
  255. 253.
    Churg A. Non-neoplastic diseases caused by asbestos. In: Churg A, Green FHY, eds. Pathology of occupational lung diseases. New York: Igaku-Shoin, 1988: 253–277.Google Scholar
  256. 254.
    Churg A, Wright JL. Small airway lesions in patients exposed to nonasbestos mineral dusts. Hum Pathol 1983; 14: 688–693.PubMedCrossRefGoogle Scholar
  257. 255.
    Wright JL, Cagle P, Churg A, Colby TV, Myers J. Diseases of the small airways. Am Rev Respir Dis 1992; 146: 240–262.PubMedCrossRefGoogle Scholar
  258. 256.
    Wagner JC, Newhouse ML, Corrin B, et al. Correlation between fibre content of the lung and disease in East London asbestos factory workers. Br J Ind Med 1988; 45: 305–308.PubMedGoogle Scholar
  259. 257.
    Vorward AJ, Durkan TM, Pratt PC. Experimental studies of asbestosis. Arch Ind Hyg Occup Med 1951; 3: 1–43.Google Scholar
  260. 258.
    Wright GW, Kuschner M. The influence of varying length of glass and asbestos fibers on tissue response in guinea pigs. In: Walton WH, ed. Inhaled particles IV. Oxford: Pergamon Press, 1977: 455–474.Google Scholar
  261. 259.
    Davis JMG, Beckett ST, Bolton RE, Collings P, Middleton AP. Mass and the number of fibers in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer 1978; 37: 673–688.PubMedCrossRefGoogle Scholar
  262. 260.
    Crapo JD, Barry BE, Brody AR, O’Neil JJ. Morphological, morphometric and x-ray microanalytical studies on lung tissue of rats exposed to chrysotile asbestos in inhalation chambers. In: Wagner JC, ed. Biological effects of mineral fibers. Lyon, France: IARC Scientific Publications, 1980: 273–283.Google Scholar
  263. 261.
    Davis JMG, Addison J, Bolton RE, Donaldson K, Jones AD, Smith T. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats to inhalation and intraperitoneal injection. Br J Exp Pathol 1986; 67: 415–430.PubMedGoogle Scholar
  264. 262.
    Adamson IYR, Bowden DH. Response of mouse lungs to crocidolite asbestos. I. Mineral fibrotic reaction to short fibers. J Pathol 1987; 152: 99–107.PubMedCrossRefGoogle Scholar
  265. 263.
    Adamson IYR, Bowden DH. Response of mouse lungs to crocidolite asbestos. II. Pulmonary fibrosis after long fibres. J Pathol 1987; 152: 109–117.PubMedCrossRefGoogle Scholar
  266. 264.
    McDonald AD, Fry JS, Woolley AJ, McDonald JC. Dust exposure and mortality in an American chrysotile textile plant. Br J Ind Med 1983; 40: 361–367.PubMedGoogle Scholar
  267. 265.
    Gylseth B, Churg A, Davis JMG, et al. Analysis of asbestos fibers and asbestos bodies in tissue samples from human lung: An international interlaboratory trial. Scand J Work Environ Health 1985; 11: 107–110.PubMedCrossRefGoogle Scholar
  268. 266.
    Bellis D, Andrion A, Desedime L, et al. Minimal pathologic changes of the lung and asbestos exposure. Hum Pathol 1989; 20: 102–106.PubMedCrossRefGoogle Scholar
  269. 267.
    Rom WN, Travis WD, Brody AR. Cellular and molecular basis of asbestos-related diseases. Am Rev Respir Dis 1991; 143: 408–422.PubMedCrossRefGoogle Scholar
  270. 268.
    Hartman DP. Immunological consequences of asbestos exposure. Immunol Rev 1985; 4: 65–68.Google Scholar
  271. 269.
    Kagan E. The alveolar macrophage: Immune derangement and asbestos-related malignancy. Semin Oncol 1980; 8: 258–267.Google Scholar
  272. 270.
    Spurzem JR, Saltini C, Rom W, et al. Mechanism of macrophage accumulation in the lungs of asbestos subjects. Am Rev Respir Dis 1987; 136: 276–280.PubMedCrossRefGoogle Scholar
  273. 271.
    Dubois CM, Bissonnette E, Rola-Pleszycynski M. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Am Rev Respir Dis 1989; 139: 1257–1264.PubMedCrossRefGoogle Scholar
  274. 272.
    Lemaire I, Beaudoin H, Masse S, et al. Alveolar macrophage stimulation of lung fibroblast growth in asbes-tos-induced pulmonary fibrosis. Am J Pathol 1986; 122: 205–211.PubMedGoogle Scholar
  275. 273.
    Timbre11 V, Ashcroft T, Goldstein B, et al. Relationships between retained amphibole fibers and fibrosis in human lung tissue specimens. Ann Occup Hyg 1988; 32: 323–340.CrossRefGoogle Scholar
  276. 274.
    Begin R, Masse S, Bureau MA. Morphologic features and function of the airways in early asbestosis in the sheep model. Am Rev Respir Dis 1982; 126: 870–876.PubMedGoogle Scholar
  277. 275.
    Harless KW, Watanabe S, Renzetti AD. The acute effects of chrysotile asbestos exposure on lung function. Environ Res 1978; 16: 360–372.PubMedCrossRefGoogle Scholar
  278. 276.
    Jodoin G, Gibbs GW, Macklem PT, McDonald JC, Becklake MR. Early effects of asbestos exposure on lung function. Am Rev Respir Dis 1971; 104: 525–535.PubMedGoogle Scholar
  279. 277.
    Jacob G, Bohling H. Das verhalten des bronchial-baumes bei der asbestaublunge. Arch Gewerbepathol Gewerbehyg 1960; 18: 247–257.PubMedGoogle Scholar
  280. 278.
    Pinkerton KE, Plopper GC, Mercer RR, et al. Airway branching patterns influence asbestos fiber location and the extent of tissue injury in the pulmonary parenchyma. Lab Invest 1986; 55: 688–695.PubMedGoogle Scholar
  281. 279.
    Delfino R, Ernst P, Bourbeau J. Relationship of lung geometry to the development of pleural abnormalities in insulation workers exposed to asbestos. Am J Ind Med 1989; 15: 417–425.PubMedCrossRefGoogle Scholar
  282. 280.
    Churg A, Tron V, Wright JL. Effects of cigarette smoke exposure on retention of asbestos fibers in various morphologic compartments of the guinea pig lung. Am J Pathol 1987; 129: 385–393.PubMedGoogle Scholar
  283. 281.
    McFadden D, Wright J, Wiggs B, et al. Cigarette smoke increases the penetration of asbestos fibers into airway walls. Am J Pathol 1986; 123: 95–99.PubMedGoogle Scholar
  284. 282.
    Barnhart S, Thornquist M, Omen GS, et al. The degree of roentgenographic parenchymal opacities attributable to smoking among asbestos-exposed subjects. Am Rev Respir Dis 1990; 141: 1102–106.PubMedCrossRefGoogle Scholar
  285. 283.
    Blanc PD, Gamsu G. The effect of cigarette smoking on the detection of small radiographic opacities in organic dust diseases. J Thorac Imag 1988; 3: 51–56.CrossRefGoogle Scholar
  286. 284.
    Weiss W. Cigarette smoking and small irregular opacities. BrJ Ind Med 1991; 48: 841–844.Google Scholar
  287. 285.
    Weiss W. Smoking and pulmonary fibrosis. J Occup Med 1988; 30: 33–39.PubMedGoogle Scholar
  288. 286.
    Huuskonen MS. The clinical features, mortality and survival of patients with asbestosis. Scand J Work Environ Health 1978; 4: 265–274.PubMedCrossRefGoogle Scholar
  289. 287.
    Murphy RL, Becklake MR, Brooks SM, et al. The diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 1986; 134: 363–368.Google Scholar
  290. 288.
    Becklake MR. Asbestosis criteria. Arch Pathol Lab Med 1984; 108: 93.PubMedGoogle Scholar
  291. 289.
    Robinson BWS, Rose AH, James A, Whitaker D, Musk AW. Alveolitis of pulmonary asbestosis: Bronchoalveolar lavage studies in crocidolite-and chrysotile-exposed individuals. Chest 1986; 90: 396–402.PubMedCrossRefGoogle Scholar
  292. 290.
    Gaensler EA, Jederline PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis 1991; 144: 689–696.PubMedCrossRefGoogle Scholar
  293. 291.
    Roggli VL. Scanning electron microscopic analysis of mineral fiber content of lung tissues in the evaluation of diffuse pulmonary fibrosis. Scanning Microsc 1991; 5: 71–83.PubMedGoogle Scholar
  294. 292.
    Monso E, Tura JM, Morell F, Ruiz J, Morera J. Lung dust content in idiopathic pulmonary fibrosis: A study with scanning electron microscopy and energy-dispersive x-ray analysis. Br J Ind Med 1991; 48: 327–331.PubMedGoogle Scholar
  295. 293.
    Hillerdal G, Hemmingson A. Pulmonary pseudotumors and asbestos. Acta Radiol Diagn 1980; 21 (Facs. 5): 615–620.Google Scholar
  296. 294.
    Lynch DA, Gamsu G, Ray CS, Aberle DR. Asbestos-related focal lung masses: manifestations on conventional and high-resolution CT scans. Radiology 1988; 169: 603–607.PubMedGoogle Scholar
  297. 295.
    Case Records of the Massachusetts General Hospital. Case 73–1961. N Engl J Med 1961; 265: 745–751.Google Scholar
  298. 296.
    Saldana MJ. Localized asbestos pneumonia. Lab Invest 1981;44:57A–58A (abstr.).Google Scholar
  299. 297.
    Spencer H. The pneumoconioses and other occupational lung diseases. In: Pathology of the lung. 3d Ed. Oxford: Pergamon Press, 1977: 427–429.Google Scholar
  300. 298.
    Hammar SP, Hallman KO. Localized inflammatory pulmonary disease in persons occupationally exposed to asbestos. Chest 1993; 103: 1792–1799.PubMedCrossRefGoogle Scholar
  301. 299.
    Keith I, Day R, Lemaire S, Lemaire I. Asbestos-induced fibrosis in rats: Increase in lung mast cells and autocoid contents. Exp Lung Res 1987; 13: 311–327.PubMedCrossRefGoogle Scholar
  302. 300.
    Corrin B, Price AB. Electron microscopic studies in desquamative interstitial pneumonia associated with asbestos. Thorax 1972; 27: 324–331.PubMedCrossRefGoogle Scholar
  303. 301.
    Freed JA, Miller A, Gordon RE, Fischbein A, Kleiner-man J, Langer AM. Desquamative interstitial pneumonia associated with chrysotile asbestos fibers. Br J Ind Med 1991; 48: 332–337.PubMedGoogle Scholar
  304. 302.
    Hillerdal G, Heckscher T. Asbestos exposure and Aspergillus infection. Eur J Respir Dis 1982; 63: 420–424.PubMedGoogle Scholar
  305. 303.
    Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis. Thorax 1952; 7: 317–333.PubMedCrossRefGoogle Scholar
  306. 304.
    Roggli VL, Johnson WW, Kaminsky DB. Asbestos bodies in fine needle aspirates of the lung. Acta Cytol 1984; 28: 493–498.PubMedGoogle Scholar
  307. 305.
    Monseur J, Leguene B, Lebouffant L, Tichoux G. Asbestose du col vesical et de la prostate. J Urol 1986; 92: 17–21.Google Scholar
  308. 306.
    De Vuyst P, Dumortier P, Schandene L, Esenne M, Verhest A, Yernault J. Sarcoid-like lung granulomatosis induced by aluminum dusts. Am Rev Respir Dis 1987; 135: 493–497.PubMedGoogle Scholar
  309. 307.
    Rom WN, Travis WD. Lymphocyte-macrophage alveolitis in non-smoking individuals occupationally exposed to asbestos. Chest 1992; 101: 779–786.PubMedCrossRefGoogle Scholar
  310. 308.
    Greenberg SD, Roggli VL. Carcinoma of the lung. In: Roggli VL, Greenberg SD, Pratt PC, eds. Boston: Little Brown, 1992: 189–210.Google Scholar
  311. 309.
    Wood WB, Gloyne SR. Pulmonary asbestosis: a review of one hundred cases. Lancet 1934;ii:1383–1385.Google Scholar
  312. 310.
    Gloyne SR. Two cases of squamous carcinoma of the lung occurring in asbestosis. Tubercle 1935; 17: 5–10.CrossRefGoogle Scholar
  313. 311.
    Egbert DS, Geiger AJ. Pulmonary asbestosis and carcinoma: Report of a case with necropsy findings. Am Rev Tuberc 1936; 34: 143–150.Google Scholar
  314. 312.
    Hruby AJ, Sweany HC. Primary carcinoma of lung with special reference to incidence, early diagnosis and treatment. Arch Intern Med 1933; 52: 497–540.CrossRefGoogle Scholar
  315. 313.
    Klotz O, Simpson W. Silicosis and carcinoma of lung. Libman Annu 1932; 2: 685–691.Google Scholar
  316. 314.
    Obendorfer S. Das lungenkarzinom. Munchen Med Wochenschr 1933; 80: 688–696.Google Scholar
  317. 315.
    Lynch KM, Smith WA. Pulmonary asbestosis. III. Carcinoma of the lung in asbestosis. Am J Cancer 1936; 14: 56–64.Google Scholar
  318. 316.
    Nordmann M. Der Berufskrebs der Asbestarbeiter. Z Krebsforsch 1938; 47: 288–302.Google Scholar
  319. 317.
    Nordmann M, Sorge A. Lungenkrebs durch Asbestaub im Tierversuch. Z Krebsforsch 1941; 51: 168–178.CrossRefGoogle Scholar
  320. 318.
    Wedler HW. Uber den Lungenkrebs bei Asbestose. Dtsch Med Wochenschr 1943; 69: 575–576.CrossRefGoogle Scholar
  321. 319.
    Merewether ERA. Annual Report of the Chief Inspector of Factories for the Year 1947. London: HM Stationery Office, 1949: 78–81.Google Scholar
  322. 320.
    Enterline PE. Asbestos and cancer: The international lab. Am Rev Respir Dis 1978; 118: 975–978.PubMedGoogle Scholar
  323. 321.
    Berry G. Changing opinions and attitudes regarding asbestos and cancer. Am J Ind Med 1992; 22: 447–448.PubMedCrossRefGoogle Scholar
  324. 322.
    Bignon J. How are we going to change our attitudes and opinions regarding asbestos and cancer in the next 20 years? Am J Ind Med 1992; 22: 443–446.PubMedCrossRefGoogle Scholar
  325. 323.
    Egilman DS. Public health and epistemology. Am J Ind Med 1992; 22: 457–459.PubMedCrossRefGoogle Scholar
  326. 324.
    Lerman Y. Asbestos and cancer 1943–1965. And what happened thereafter? Am J Ind Med 1992; 22: 455–456.CrossRefGoogle Scholar
  327. 325.
    Levin SM. Prevention delayed is prevention denied. Am J Ind Med 1992; 22: 435–446.PubMedCrossRefGoogle Scholar
  328. 326.
    Morgan RW. Attitudes about asbestos and lung cancer. Am J Ind Med 1992; 22: 437–441.PubMedCrossRefGoogle Scholar
  329. 327.
    Schepers GWH. Changing attitudes and opinions: Asbestos and cancer, 1934–1965. Am J Ind Med 1992; 22: 461–466.PubMedCrossRefGoogle Scholar
  330. 328.
    Wikeley NJ. Asbestos and cancer: An early warning to the British TVC. Am J Ind Med 1992; 22: 449–454.PubMedCrossRefGoogle Scholar
  331. 329.
    Keane J. Changing attitudes and opinions regarding asbestos and cancer, 1934–1965. Am J Ind Med 1992; 22: 429–433.PubMedCrossRefGoogle Scholar
  332. 330.
    Doll R. Mortality from lung cancer in asbestos workers. Br J Ind Med 1955; 12: 81–86.PubMedGoogle Scholar
  333. 331.
    McDonald JG. Asbestos and lung cancer: Has the case been proven? Chest 1980; 67 (Suppl.): 374–376.Google Scholar
  334. 332.
    Acheson ED, Gardner MJ. The ill effects of asbestos on health. In: Health and Safety Commission. Asbestos. Final Report of the Advisory Committee, Vol. 2. London: HM Stationery Office, 1979: 7–84.Google Scholar
  335. 333.
    Selikoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia. JAMA 1964; 188: 22–26.PubMedCrossRefGoogle Scholar
  336. 334.
    Browne K. Asbestos-related malignancy and the cairns hypothesis. Br J Ind Med 1991; 48: 73–76.PubMedGoogle Scholar
  337. 335.
    Boyland E. Tumour initiators, promoters and corn plete carcinogens. Br J Ind Med 1985; 42: 716–718.PubMedGoogle Scholar
  338. 336.
    Trosic I, Horvat D, Stilinovic L, Pisl Z. Cytotoxic, hemolytic and mutagenic issue caused by chyrsotile asbestos in vitro. In: Mossman BT, Begin RO, eds. Effect of mineral dusts on cells. New York: Springer-Verlag, 1988: 423–437.Google Scholar
  339. 337.
    Barrett JG, Lamb PW, Wiseman RW. Multiple mechanisms for the carcinogenic effect of asbestos and other mineral fibers. Environ Health Perspect 1989; 81: 81–89.PubMedCrossRefGoogle Scholar
  340. 338.
    Selikoff IJ, Lee DHK. Asbestos and disease. New York: Academic Press, 1982.Google Scholar
  341. 339.
    Kannerstein M, Churg J. Mesothelioma in man and experimental animals. Environ Health Perspect 1980; 34: 31–36.PubMedCrossRefGoogle Scholar
  342. 340.
    Hesterberg TW, Barett JC. Induction by asbestos fibers of anaphase abnormalities: Mechanism for aneuploidy induction and possible carcinogenesis. 1985; 6: 473–475.Google Scholar
  343. 341.
    Craighead JE, Akley NJ, Gould LB, Libbus BNL. Characteristics of tumors and tumor cells cultured from experimental and asbestos-induced mesotheliomas in rats. Am J Pathol 1987; 129: 448–462.PubMedGoogle Scholar
  344. 342.
    Lechner JF, Tokiwa T, LaVeck MA, et al. Asbestos-associated chromosomal changes in human mesothelial cells. Proc Natl Acad Sci USA 1985; 82: 3884–3888.PubMedCrossRefGoogle Scholar
  345. 343.
    Fatima N, Jain AK, Rahman Q. Frequency of sister chromatid exchange and chromosomal aberrations in asbestos cement workers. Br J Ind Med 1991; 148: 103–105.Google Scholar
  346. 344.
    Rom WN, Livingston GK, Casey KR, et al. Sister chromatid exchange frequency in asbestos workers. J Natl Cancer Inst 1983; 70: 45–48.PubMedGoogle Scholar
  347. 345.
    International Agency for Research on Cancer. Evaluation of the carcinogenic risk of chemicals to humans. IARC Monograph 1–29(4). Geneva: World Health Organizationa, 1982.Google Scholar
  348. 346.
    Walker C, Everett J, Barret JC. Possible cellular and molecular mechanisms for asbestos carcinogenicity. Am J Ind Med 1992; 21: 253–273.PubMedCrossRefGoogle Scholar
  349. 347.
    Selikoff EJ, Hammond EC, Churg J. Asbestos exposure, smoking, and neoplasia. JAMA 1968; 204: 104110.Google Scholar
  350. 348.
    Saracci R. The interactions of tobacco smoking and other agents in cancer etiology. Epidemiol Rev 1987; 175–193.Google Scholar
  351. 348a.
    Liddell FDK, Thomas DC, Gibbs JW, et al. Fibre exposure and mortality from pneumoconiosis, respiratory and abdominal malignancies in chrysotile production in Quebec, 1926–75. Singapore Ann Acad Med 1984; 13 (Suppl 2): 340–344.Google Scholar
  352. 348b.
    Baker JE. Lung cancer incidence amongst previous employees of an asbestos mine in relationship to crocidolite exposure and tobacco smoking. PhD thesis, University of Western Australia, Perth, 1985.Google Scholar
  353. 348c.
    Selikoff IJ, Seidman H, Hammond EC. Mortality effects of cigarette smoking among amosite asbestos factory workers. JNCI 1980; 65: 507–513.PubMedGoogle Scholar
  354. 348d.
    Acheson ED, Gardner MJ, Winter PD, et al. Cancer in a factory using amosite asbestos. Int J Epidemiol 1984; 13: 3–10.PubMedCrossRefGoogle Scholar
  355. 348e.
    Berry G, Newhouse ML, Antonis P. Combined effect of asbestos exposure and smoking on mortality from lung cancer in factory workers. Lancet 1972;2:476–479.Google Scholar
  356. 348f.
    Berry G, Newhouse ML, Antonis P. Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Lancet 1972;2: 476–479.Google Scholar
  357. 348g.
    Selikoff IJ, Hammond ED. Multiple risk factors in environmental cancer. In: Fraumeni J, ed. Persons at high risk of cancer. New York: Academic Press, 1975: 467–483.Google Scholar
  358. 348h.
    Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cagarette smoking and death rates. Ann NY Acad Sci 1979; 330: 473–490.PubMedCrossRefGoogle Scholar
  359. 348i.
    Blot WJ, Harrington JM, Toledo A, et al. Lung cancer after enployment in shipyards during World War II. N Engl J Med 1978; 299: 620–624.PubMedCrossRefGoogle Scholar
  360. 348j.
    Blot WJ, Morris LE, Stroube R, et al. Lung and laryngeal cancer in relation to shipyard employment in coastal Virginia. JNCI 1980; 65: 571–575.PubMedGoogle Scholar
  361. 348k.
    Martischnig KM, Newell DJ, Barnsley WC, et al. Unsuspected exposure to asbestos and bronchogenic carcinoma. Br Med J 1977; 1: 746–749.PubMedCrossRefGoogle Scholar
  362. 3481.
    Pastorino U, Berrino F, Gervasio A, et al. Proportion of lung cancers due to occupational exposure. Int J Cancer 1984; 33: 231–237.PubMedCrossRefGoogle Scholar
  363. 348m.
    Kijuus H, Skjaerven R, Langârd S, et al. A case-referent study of lung cancer, occupational exposure and smoking. 2. Role of asbestos exposure. Scand J Work Environ Health 1986; 12: 203–209.CrossRefGoogle Scholar
  364. 349.
    Berry G. Mortality of workers certified by pneumoconiosis medical panels as having asbestosis. Br J Ind Med 1981; 38: 130–137.PubMedGoogle Scholar
  365. 350.
    Finkelstein M, Kusiak R, Suranyi G. Mortality among workers receiving compensation for asbestosis in Ontario. Can Med Assoc J 1981; 125: 259–262.PubMedGoogle Scholar
  366. 351.
    Cookson WO, Most AW, Glancy JJ, et al. Compensation, radiographic changes, and survival in applicants for asbestosis compensation. Br J Ind Med 1985; 42: 461–468.PubMedGoogle Scholar
  367. 352.
    Coutts IJ, Gilson JC, Kerr IH, Parkes WR, Turner-Warwick M. Mortality in cases of asbestosis diagnosed by a pneumoconiosis medical panel. Thorax 1987; a42: 111–116.PubMedCrossRefGoogle Scholar
  368. 353.
    Weill H. Asbestos. A summing up. In: Wagner JC, ed. Biological effects of mineral fibers, Vol. 2. IARC Publication *30. Lyon: International Agency for Research on Cancer, 1980: 867–873.Google Scholar
  369. 354.
    Kipen HM, Lilis R, Suzuki V, Valciukas JA, Selikoff IJ. Pulmonary fibrosis in asbestos insulation workers with lung cancer: A radiological and histopathological evaluation. Br J Ind Med 1987; 44: 96–100.PubMedGoogle Scholar
  370. 355.
    Newhouse ML, Berry G, Wagner JC. Mortality of factory workers in East London, 1933–1980. Br J Ind Med 1985; 42: 4–11.PubMedGoogle Scholar
  371. 356.
    Sluis-Cremer GK, Bezuidenhout BN. Relation between asbestosis and bronchial cancer in amphibole miners. Br J Ind Med 1989; 46: 537–540.PubMedGoogle Scholar
  372. 357.
    Hughes HJM, Weill H. Asbestosis as a precursor of asbestos-related lung cancer: Results of a prospective mortality study. Br J Ind Med 1991; 48: 229–233.PubMedGoogle Scholar
  373. 358.
    Browne K. Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers? Br J Ind Med 1986; 43: 145–149.PubMedGoogle Scholar
  374. 359.
    Kiviluoto R, Meurman LO, Hakama M. Pleural plaques and neoplasia in Finland. Ann NY Acad Sci 1979; 330: 31–33.PubMedCrossRefGoogle Scholar
  375. 360.
    Edge JR. Incidence of bronchial carcinoma in shipyard workers with pleural plaques. Ann NY Acad Sci 1979; 330: 289–294.PubMedCrossRefGoogle Scholar
  376. 361.
    Hillerdal G. Pleural plaques and risks for cancer in the county of Uppsala. Eur J Resp Dis 1980;61(10):111–117 (Suppl.).Google Scholar
  377. 362.
    Mollo F, Andrion A, Colombo A, Segnan N, Pira E. Pleural plaques and risk of cancer in Turin, Northwestern Italy. Cancer (Philadelphia) 1984; 54: 1418–1422.CrossRefGoogle Scholar
  378. 363.
    Harber P, Mohsenifar Z, Oren A, Lew M. Pleural plaques and asbestos-associated malignancy. J Occup Med 1987; 29: 641–644.PubMedGoogle Scholar
  379. 364.
    Hillerdal G. Risk and type of lung cancer and mesothelioma in patients with pleural plaques. Lung Cancer 1991; 7 (Suppl.): 5.CrossRefGoogle Scholar
  380. 365.
    Partanen T, Nurimen M, Zitting A, Koskinen H, Wiikeri M, Ahlman K. Localized pleural plaques and lung cancer. Am J Ind Med 1992; 22: 185–192.PubMedCrossRefGoogle Scholar
  381. 366.
    Parkes WR. Occupational Lung disorders. 2d Ed. London: Butterworths, 1982.Google Scholar
  382. 367.
    Medical Advisory Panel to the Asbestos International Association. Criteria for the diagnosis of asbestosis and considerations in the attribution of lung cancer and mesothelioma to asbestos exposure. Int Arch Occup Environ Health 1982; 49: 357–361.Google Scholar
  383. 368.
    Whitwell F, Newhouse MI, Bennett DR. A study of the histological types of lung cancer in workers suffering from asbestosis in the United Kingdom. Br J Ind Med 1974; 31: 298–303.PubMedGoogle Scholar
  384. 369.
    Churg A. Lung cancer cell type and asbestos exposure. JAMA 1985; 253: 2984–2985.PubMedCrossRefGoogle Scholar
  385. 369a.
    Hourihane DO’B, McCaughey WTE. Pathological aspects of asbestosis. Postgrad Med J 1966; 42: 613–622.Google Scholar
  386. 369b.
    Whitwell F, Newhouse ML, Bennett DR. A study of the histological types of lung cancer in workers suffering from asbestosis in the United Kingdom. Br J Ind Med 1974; 31: 298–303.PubMedGoogle Scholar
  387. 369c.
    Hasan FM, Nash G, Kazemi H. Asbestos exposure and related neoplasia. Am J Med 1978; 65: 649–654.PubMedCrossRefGoogle Scholar
  388. 369d.
    Kannerstein M, Churg J. Pathology of carcinoma of the lung associated with asbestos exposure. Cancer 1972; 30: 14–21.PubMedCrossRefGoogle Scholar
  389. 369e.
    Martischnig KM, Newell DJ, Barnsley WC, et al. Unsuspected exposure to asbestos and bronchogenic carcinoma. Br Med J 1977; 1: 746–749.PubMedCrossRefGoogle Scholar
  390. 369f.
    Finkelstein MM. Asbestosis in long-term employees of an Ontario asbestos-cement factory. Am Rev Respir Dis 1982; 125: 496–501.PubMedGoogle Scholar
  391. 369g.
    Ives JC, Buffler PA, Greenberg D. Environmental associations and histopathologic patterns of carcinoma of the lung. Am Rev Respir Dis 1983; 128: 195–209.PubMedGoogle Scholar
  392. 369h.
    Auerbach O, Garfinkel L, Parks VR, et al. Histologic type of lung cancer and asbestos exposure. Cancer 1984; 54: 3017–3021.PubMedCrossRefGoogle Scholar
  393. 370.
    Jacob G, Anspach M. Pulmonary neoplasia among Dresden asbestos workers. Ann NY Acad Sci 1965; 132: 536–548.PubMedCrossRefGoogle Scholar
  394. 371.
    Hueper WC. Occupational and environmental cancers of the respiratory system: New York: Springer-Verlag, 1966: 43.Google Scholar
  395. 372.
    Kannerstein M, Churg J. Pathology of carcinoma of the lung associated with asbestos exposure. Cancer (Philadelphia) 1972; 30: 14–21.CrossRefGoogle Scholar
  396. 373.
    Huuskonen MS. Clinical features, mortality and survival of patients with asbestosis. Scand J Work Environ Health 1978; 265–274.Google Scholar
  397. 374.
    Garland LH, Beier RL, Coulson W, Heald JH, Stein RL. The apparent sites of origin of carcinomas of the lung. Radiology 1962; 78: 1–11.PubMedGoogle Scholar
  398. 375.
    Lulu DJ, Lawson LJ. Carcinoma of the lung. Arch Surg 1964; 88: 213–217.PubMedCrossRefGoogle Scholar
  399. 376.
    Weiss W, Boucot KR. The Philadelphia pulmonary neoplasm research project: Early roentgenographic appearance of bronchogenic carcinoma. Arch Intern Med 1974; 134: 306–311.PubMedCrossRefGoogle Scholar
  400. 377.
    Byers TE, Vena JE, Rzepka TF. Predilection of lung cancer for the upper lobes: An epidemiologic survey. J Natl Cancer Inst 1984; 72: 1271–1275.PubMedGoogle Scholar
  401. 378.
    Weiss W. Lobe of origin in the attribution of lung cancer to asbestos. Br J Ind Med 1988; 45: 544–547.PubMedGoogle Scholar
  402. 379.
    Auerbach O, Garfinkel L, Parks VR, Conston A, Galdi V, Joubert L. Histologic type of lung cancer and asbestos exposure. Cancer (Philadelphia) 1984; 54: 3017–3021.CrossRefGoogle Scholar
  403. 380.
    Babolini G, Blasi A. The pleural form of primary cancer of the lung. Dis Chest 1956; 29: 314–323.PubMedCrossRefGoogle Scholar
  404. 381.
    Verga P, Botteri G. Il carcinoma primitivo del pulmone. Cappelli, ed. Bologne: 1931.Google Scholar
  405. 382.
    Liberti R, Stella G. Il cancro primitivo del pulmone. E.A.T., Napoli, 1949.Google Scholar
  406. 383.
    Sival L. La neoplasia primitiva polmonare: Rapporti tra tipo istologico, sede e gli altri principali caratteri. Biol Lat 1951; 4: 212.Google Scholar
  407. 384.
    Harwood TR, Gracey Dr, Yokoo H. Pseudomesotheliomatous carcinoma of the lung: A variant of peripheral lung cancer. Am J Clin Pathol 1976; 65: 159–167.PubMedGoogle Scholar
  408. 385.
    Koss M, Tra-vis W, Moran C, Hochholzer L. Pseudomesotheliomatous adenocarcinomas: A reappraisal. Semin Diagn Pathol 1992; 9: 117–123.PubMedGoogle Scholar
  409. 386.
    Simonsen J. Pseudomesotheliomatous carcinoma of the lung with asbestos exposure. Am J Forensic Med Pathol 1986; 7: 49–51.PubMedCrossRefGoogle Scholar
  410. 387.
    Nishimoto Y, Ohno T, Saito K. Pseudomesotheliomatous carcinoma of the lung with histochemical and immunohistochemical study. Acta Pathol Jpn 1983; 33: 415–423.PubMedGoogle Scholar
  411. 388.
    Lin JI, Tyy Seng CH, Tsung SH. Pseudomesotheliomatous carcinoma of the lung. South Med J 1980; 73: 655–656.PubMedCrossRefGoogle Scholar
  412. 389.
    Brganza JM, Butler EB, Fox H, et al. Ectopic production of salivary type amylase by a pseudomesotheliomatous carcinoma of the lung. Cancer (Philadelphia) 1978; 41: 1522–1525.CrossRefGoogle Scholar
  413. 390.
    Broghamer WL, Jr., Collins WM, Mojsenjenko IK. The cytohistopathology of a speudomesotheliomatous carcinoma of the lung. Acta Cytol 1978; 22: 239–242.PubMedGoogle Scholar
  414. 391.
    Dessy E, Pietra GG. Pseudomesotheliomatous carcinoma of the lung: An immunohistochemical and ultra-structural study of three cases. Cancer (Philadelpha) 1991; 68: 1747–1753.CrossRefGoogle Scholar
  415. 392.
    Robb JA, Hammar SP, Yokoo H. Pseudomesotheliomatous lung carcinoma: A rare asbestos-related malignancy readily separable from epithelial pleural mesothelioma. Hum Pathol (in press).Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Samuel P. Hammar
  • Ronald F. Dodson

There are no affiliations available

Personalised recommendations